X
    アカデミックビジュアライゼーションスタジオRC   ログイン (EN)   原稿を依頼する (EN)
学術英語編集

Ophthalmology and Therapy

ジャーナルタイトルで検索 OPHTHALMOL THER 最新のコメント: なぜ払い戻しができないのですか? (2022-09-04)


ジャーナル名:   ISSN:   主題分野:   インパクトファクタ範囲: -
インデックス:   カテゴリー:   オープンアクセス:   Sort by:

[Ophthalmology and Therapy]こんにちは、このページの訪問者は9638番目です。

ジャーナル プロフィール
ジャーナル タイトルOphthalmology and Therapy Ophthalmology and Therapy
LetPub Score
7.0
50 ratings
Rate

Reputation
8.7

Influence
5.6

Speed
7.1

ジャーナルの略称OPHTHALMOL THER
ISSN2193-8245
E-ISSN2193-6528
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.201.1581.280
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q239 / 137

自己引用率 (2023-2024)3.80%自己引用率トレンド
掲載範囲
Aims and Scope



Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques.



The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.



Rapid Publication



The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies.



Open Access

All articles published by Ophthalmology and Therapy are open access.



Personal Service



The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.



Digital Features and Plain Language Summaries



Ophthalmology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.



For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/



Publication Fees



Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.



Peer Review Process



Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.



At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor.



Preprints



We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.

Please follow the link for further information on preprint sharing:

https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550



Copyright



Ophthalmology and Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.



Contact



For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.
公式サイトhttps://www.springer.com/40123
オンライン原稿提出https://www.editorialmanager.com/opth
オープンアクセスYes
出版社SPRINGER INTERNATIONAL PUBLISHING AG
主題分野OPHTHALMOLOGY
出版国/地域ENGLAND
発行頻度年6回刊行
発行開始年0
年間記事数196年間記事数トレンド
ゴールド OA 割合99.79%
OA Related Info
APC: Yes( EUR5500; USD6850; GBP4700; )
APC waiver:Check Notes
Other charges: No
Keywords: ophthalmology、eye surgery
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ226/95
インデックス (SCI or SCIE)Science Citation Index Expanded
PubMed Central (PMC) へのリンクhttps://www.ncbi.nlm.nih.gov/nlmcatalog?term=2193-8245%5BISSN%5D
平均査読期間 *出版社からの許可を得たデータ:
著者からのデータ: 6 Weeks
競争力 *著者からのデータ:
参考になるリンク
関連するジャーナル 【Ophthalmology and Therapy】CiteScoreトレンド
自己引用率トレンド 年間記事数トレンド
著者のコメント
*すべてのレビュープロセスの指標、例えば受理率やレビューの速さは、ユーザーが提出した原稿に限定されています。そのため、これらの指標はジャーナルの正確な競争力や速さを反映していない可能性があります。
  • 同じ学問分野のジャーナル
  • CiteScoreトレンド
  • 自己引用率トレンド
  • 年間記事数トレンド
  •  
    学問分野内の信頼できるジャーナル インパクトファクター
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    学問分野内で最も検索されたジャーナル ページビュー
    BIOMATERIALS704184
    MEDICINE651522
    JOURNAL OF ETHNOPHARMACOLOGY528559
    Frontiers in Pharmacology516906
    BIOMEDICINE & PHARMACOTHERAPY499495
    Journal of Materials Chemistry B476429
    Frontiers in Immunology465948
    COMPUTERS IN BIOLOGY AND MEDICINE425801
    COLLOIDS AND SURFACES B-BIOINTERFACES420292
    Frontiers in Oncology419686
  •  

    Ophthalmology and Therapy Ophthalmology and Therapy
    来年の予測:
    着実な増加 変化なし 徐々に減少  更新する
  •  

     
  •  

     


最初    前へ    1    次へ    最後  (ページ
/1)
  [Ophthalmology and Therapy] のレビューレビューを書く
著者: 田田爱学习吖


分野: 医学
査読期間: 0.0 month(s)
結果: 保留中&不明


レビューを書く

2022-09-04 17:14:20 レビューした
なぜ払い戻しができないのですか?
(0) いいね! | 田田爱学习吖

著者: 大虎


分野: 医学
査読期間: 1.0 month(s)
結果: 改訂後に受け入れられました


レビューを書く

2022-02-22 14:41:02 レビューした
レビューが非常に速かった、想像を超えるほど。10月5日に提出し、2週間後に軽微な修正コメントを受け取り、10月29日に受理され、11月11日にオンラインで公開された。ただ高い。$6000もかかる。もう一度提出する勇気がない、返金されないのではと心配して
(3) いいね! | 大虎

最初    前へ    1    次へ    最後  (ページ
/1)

[Ophthalmology and Therapy] のレビューを書き始める:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*

>